Literature DB >> 29369004

A modified Essen Stroke Risk Score for predicting recurrent ischemic stroke at one year.

Xia Ling1, Shuang-Mei Yan1, Bo Shen2, Xu Yang1.   

Abstract

Objective The Essen Stroke Risk Score (ESRS) is widely used to predict the risk of recurrent ischemic stroke but may not have sufficient discriminatory ability for predicting early recurrence. In this study, we developed a modified ESRS for predicting recurrent ischemic stroke at one year based on Chinese population. Methods Eight hundred and three consecutive patients were included in the study. We performed a univariate analysis to investigate the effect of previously identified risk factors on recurrent stroke at one year. The candidate predictors were included in a forward stepwise logistic regression model. Prediction scores were assigned based on β coefficient and a modified ESRS system was constructed. We used receiver operating characteristic (ROC) curves to compare the predictive ability of the modified and original ESRS. Results Recurrent ischemic stroke occurred in 85 (11.00%) patients and death occurred in 68 (8.80%) patients within one year. Hypertension over 15 years, diabetes over 10 years, large artery atherosclerosis cerebral infarction by TOAST criteria and a history of transient ischemic attack (TIA) or ischemic stroke (IS) were identified as independent risk factors for recurrent stroke (all P < 0.05). The areas under the ROC curves of ESRS and modified ESRS were 0.58 (P < 0.05, 95%CI: 0.51-0.64) and 0.70 (P < 0.05, 95% CI: 0.63-0.76), respectively. The modified ESRS appears to be superior to the original ESRS for predicting recurrent ischemic stroke at one year (P < 0.05). Conclusions The modified ESRS increased the ability of the original ESRS to predict recurrent stroke at one year among the Chinese population.

Entities:  

Keywords:  Essen Stroke Risk Score (ESRS); Ischemic stroke; predictive ability; recurrent stroke; risk

Mesh:

Year:  2018        PMID: 29369004     DOI: 10.1080/01616412.2018.1428389

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  6 in total

1.  Recurrent ischemic stroke in patients with atrial fibrillation ablation and prior stroke: A study based on etiological classification.

Authors:  Seiji Fukamizu; Rintaro Hojo; Takeshi Kitamura; Iwanari Kawamura; Satoshi Miyazawa; Jun Karashima; Shin Nakamura; Kosuke Takeda; Koichiro Yamaoka; Tomoyuki Arai; Kohei Kawajiri; Sho Tanabe; Yasuki Koyano; Daisuke Miyahara; Sayuri Tokioka; Marina Arai; Dai Inagaki; Tomonori Miyabe; Harumizu Sakurada; Masayasu Hiraoka
Journal:  J Arrhythm       Date:  2019-12-03

2.  Clinical risk factors associated with recurrence of ischemic stroke within two years: A cohort study.

Authors:  Yuanyuan Zhuo; Jiaman Wu; Yimin Qu; Haibo Yu; Xingxian Huang; Benny Zee; Jack Lee; Zhuoxin Yang
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.889

3.  sLOX-1: A Molecule for Evaluating the Prognosis of Recurrent Ischemic Stroke.

Authors:  Yangmin Zheng; Yuyou Huang; Lingzhi Li; Pingping Wang; Rongliang Wang; Zhen Tao; Junfen Fan; Ziping Han; Fangfang Li; Haiping Zhao; Fangfang Zhao; Feng Yan; Yumei Liu; Yumin Luo
Journal:  Neural Plast       Date:  2021-08-28       Impact factor: 3.599

4.  Essen score in the prediction of cerebrovascular events compared with cardiovascular events after ischaemic stroke or transient ischaemic attack: a nationwide registry analysis.

Authors:  Long Li; Ze-Ning Jin; Yue-Song Pan; Jing Jing; Xia Meng; Yong Jiang; Hao Li; Cai-Xia Guo; Yong-Jun Wang
Journal:  J Geriatr Cardiol       Date:  2022-04-28       Impact factor: 3.327

5.  Prediction Model Construction for Ischemic Stroke Recurrence with BP Network and Multivariate Logistic Regression and Effect of Individualized Health Education.

Authors:  Ting Lu; Yun Wang
Journal:  Comput Math Methods Med       Date:  2022-06-22       Impact factor: 2.809

6.  External Validation of the WORSEN Score for Prediction the Deterioration of Acute Ischemic Stroke in a Chinese Population.

Authors:  Yicheng Xu; Yu Chen; Ruiwei Chen; Fei Zhao; Peifu Wang; Shengyuan Yu
Journal:  Front Neurol       Date:  2020-05-29       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.